Transcriptome Analysis and Machine Learning Prioritize Therapeutic Strategies for High-Risk Pediatric AML Patients of the KMT2A-Fusion Subgroup 2022 https://researcherprofiles.org/profile/376214078 Obermayer A, Yao S, Smith JL, Ries RE, Wang Y-C, Farrar JE, Furlan SN, Triche R, Ma X, Huang BJ, Wang X, Meshinchi S, Shaw TI
